Cargando…

Nanocarrier-based drug combination therapy for glioblastoma

The current achievements in treating glioblastoma (GBM) patients are not sufficient because many challenges exist, such as tumor heterogeneity, the blood brain barrier, glioma stem cells, drug efflux pumps and DNA damage repair mechanisms. Drug combination therapies have shown increasing benefits ag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Mengnan, van Straten, Demian, Broekman, Marike L.D., Préat, Véronique, Schiffelers, Raymond M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956816/ https://www.ncbi.nlm.nih.gov/pubmed/31938069 http://dx.doi.org/10.7150/thno.38147

Ejemplares similares

Immunotherapy for glioblastoma: the promise of combination strategies
por: Bausart, Mathilde, et al.
Publicado: (2022)

Basic science in neurosurgery
por: van Solinge, Thomas S., et al.
Publicado: (2023)

Ginsenosides emerging as both bifunctional drugs and nanocarriers for enhanced antitumor therapies
por: Wang, Hong, et al.
Publicado: (2021)

Potential Use of Extracellular Vesicles Generated by Microbubble-Assisted Ultrasound as Drug Nanocarriers for Cancer Treatment
por: Yuana, Yuana, et al.
Publicado: (2020)

Lipid-Based Nanocarriers for The Treatment of Glioblastoma
por: Iturrioz-Rodríguez, Nerea, et al.
Publicado: (2020)

Magnetic targeting of paclitaxel-loaded poly(lactic-co-glycolic acid)-based nanoparticles for the treatment of glioblastoma
por: Ganipineni, Lakshmi Pallavi, et al.
Publicado: (2018)

Nanotechnology and Nanocarrier-Based Drug Delivery as the Potential Therapeutic Strategy for Glioblastoma Multiforme: An Update
por: Hsu, Jen-Fu, et al.
Publicado: (2021)

Possibilities and limitations of current technologies for quantification of biological extracellular vesicles and synthetic mimics
por: Maas, Sybren L.N., et al.
Publicado: (2015)

Combination of DNA Vaccine and Immune Checkpoint Blockades Improves the Immune Response in an Orthotopic Unresectable Glioblastoma Model
por: Bausart, Mathilde, et al.
Publicado: (2022)

A Natural Bacterium-Produced Membrane-Bound Nanocarrier for Drug Combination Therapy
por: Long, Ruimin, et al.
Publicado: (2016)

Thymine-Modified Nanocarrier for Doxorubicin Delivery in Glioblastoma Cells
por: Ziganshina, Albina Y., et al.
Publicado: (2023)

Nanocarriers Usage for Drug Delivery in Cancer Therapy
por: Khodabandehloo, Hadi, et al.
Publicado: (2016)

Synergistic effect of doxorubicin lauroyl hydrazone derivative delivered by α-tocopherol succinate micelles for the treatment of glioblastoma
por: Wang, Mingchao, et al.
Publicado: (2022)

Nanocarriers and nonviral methods for delivering antiangiogenic factors for glioblastoma therapy: the story so far
por: Clavreul, Anne, et al.
Publicado: (2019)

Heparin interferes with the uptake of liposomes in glioma
por: van Solinge, Thomas S., et al.
Publicado: (2023)

Multifunctionalized polyethyleneimine-based nanocarriers for gene and chemotherapeutic drug combination therapy through one-step assembly strategy
por: Jiang, Dandan, et al.
Publicado: (2017)

Survival prediction of glioblastoma patients—are we there yet? A systematic review of prognostic modeling for glioblastoma and its clinical potential
por: Tewarie, Ishaan Ashwini, et al.
Publicado: (2020)

Polymeric Nanocarriers of Drug Delivery Systems in Cancer Therapy
por: Avramović, Nataša, et al.
Publicado: (2020)

Nature-inspired nanocarriers for improving drug therapy of atherosclerosis
por: Ji, Weihong, et al.
Publicado: (2023)

Glioblastoma Multiforme in the Posterior Cranial Fossa in a Patient with Neurofibromatosis Type I
por: Broekman, Marike L. D., et al.
Publicado: (2009)

Design of Bio-Responsive Hyaluronic Acid–Doxorubicin Conjugates for the Local Treatment of Glioblastoma
por: Malfanti, Alessio, et al.
Publicado: (2022)

Polymer-Based Nanocarriers for Co-Delivery and Combination of Diverse Therapies against Cancers
por: Yan, Guowen, et al.
Publicado: (2018)

Nanocarrier-Based Drug Delivery for Melanoma Therapeutics
por: Song, Mingming, et al.
Publicado: (2021)

Transferrin Receptor-Targeted Nanocarriers: Overcoming Barriers to Treat Glioblastoma
por: Ramalho, Maria João, et al.
Publicado: (2022)

The Multifaceted Role of Extracellular Vesicles in Glioblastoma: microRNA Nanocarriers for Disease Progression and Gene Therapy
por: Simionescu, Natalia, et al.
Publicado: (2021)

Evaluation of Three Morphologically Distinct Virus-Like Particles as Nanocarriers for Convection-Enhanced Drug Delivery to Glioblastoma
por: Finbloom, Joel A., et al.
Publicado: (2018)

Physicochemical characterization of drug nanocarriers
por: Manaia, Eloísa Berbel, et al.
Publicado: (2017)

A drug-specific nanocarrier design for efficient anticancer therapy
por: Shi, Changying, et al.
Publicado: (2015)

Dendrimers as Nanocarriers for Nucleic Acid and Drug Delivery in Cancer Therapy
por: Palmerston Mendes, Livia, et al.
Publicado: (2017)

Metal–Organic Frameworks as Intelligent Drug Nanocarriers for Cancer Therapy
por: Cai, Xuechao, et al.
Publicado: (2022)

Glioblastoma-Associated Microglia Reprogramming Is Mediated by Functional Transfer of Extracellular miR-21
por: Abels, Erik R., et al.
Publicado: (2019)

Assessment of Hyperosmolar Blood–Brain Barrier Opening in Glioblastoma via Histology with Evans Blue and DCE-MRI
por: Conq, Jérôme, et al.
Publicado: (2023)

Nanocarriers for intracellular co-delivery of proteins and small-molecule drugs for cancer therapy
por: Cheng, Zhihong, et al.
Publicado: (2022)

Lipid-Based Nanocarriers in Renal RNA Therapy
por: Su, Chi-Ting, et al.
Publicado: (2022)

Nanocarrier-Based Targeted Therapies for Myocardial Infarction
por: George, Thomashire A., et al.
Publicado: (2022)

Layered Double Hydroxide-Based Nanocarriers for Drug Delivery
por: Bi, Xue, et al.
Publicado: (2014)

Hyaluronic Acid-Based Nanocarriers for Anticancer Drug Delivery
por: Fu, Chao-Ping, et al.
Publicado: (2023)

Illuminating cellular and extracellular vesicle-mediated communication via a split-Nanoluc reporter in vitro and in vivo
por: van Solinge, Thomas S., et al.
Publicado: (2023)

Nanocarriers, Progenitor Cells, Combinational Approaches, and New Insights on the Retinal Therapy
por: Pishavar, Elham, et al.
Publicado: (2021)

Tumor acidity activated triphenylphosphonium-based mitochondrial targeting nanocarriers for overcoming drug resistance of cancer therapy
por: Yu, Hui, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mbapu4rer7csn7lahus907nt8p